Y. Meng

Structural modifications of indolinones bearing a pyrrole moiety and discovery of a multi-kinase inhibitor with potent antitumor activity.

Haotian Zhang, Ye Tian, Mingze Qin, 2020, Bioorganic & medicinal chemistry.

Biotechnological formation of dairy flavor inducing δ-lactones from vegetable oil

P. Fuchsmann, U. von Ah, J. Kerler, 2022, Food chemistry: X.

Discovery of 4-phenylindolines containing a (5-cyanopyridin-3-yl)methoxy moiety as potent inhibitors of the PD-1/PD-L1 interaction.

Shaopeng Zhang, Yajing Liu, Mingze Qin, 2022, Bioorganic & medicinal chemistry letters.

Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction.

Li-hui Wang, Haotian Zhang, Yanfang Zhao, 2021, Journal of medicinal chemistry.

Insights into non-peptide small-molecule inhibitors of the PD-1/PD-L1 interaction: Development and perspective.

Haotian Zhang, Guowei Gong, Mingze Qin, 2021, Bioorganic & medicinal chemistry.

The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor

Mingze Qin, Jie Bao, Chun-Hui Wu, 2024, EMBO molecular medicine.

Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy.

Shaopeng Zhang, Lihui Wang, Mingze Qin, 2023, Journal of medicinal chemistry.